Related Experiment Video
Updated: Oct 20, 2025

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices
Published on: August 11, 2021
Serotonin transporter availability, neurocognitive function and their correlation in abstinent
Foke L van de Blaak1, Glenn J H Dumont1
1Department of Clinical pharmacology, Amsterdam UMC - Location AMC, University of Amsterdam, Amsterdam, the Netherlands.
MDMA use decreases serotonin transporter (SERT) availability and impairs memory. While SERT levels recover with abstinence, memory deficits persist, suggesting SERT is not a reliable biomarker for MDMA
Area of Science:
- Neuroscience
- Psychopharmacology
- Cognitive Science
Background:
- 3,4-methylenedioxymethamphetamine (MDMA), or Ecstasy, is increasingly popular among adolescents.
- MDMA's neurotoxic potential and long-term effects on neurocognition are debated.
- Studies link Ecstasy use to reduced serotonin transporter (SERT) availability and cognitive impairments.
Purpose of the Study:
- To investigate the long-term effects of MDMA on SERT availability and cognitive function.
- To determine if SERT recovery predicts cognitive recovery in MDMA users.
Main Methods:
- Literature search conducted in PubMed.
- Inclusion of studies examining both MDMA's impact on SERT availability and cognitive performance.
Main Results:
- SERT availability showed a positive correlation with abstinence duration.
- Memory performance remained impaired in MDMA users, with no significant correlation to SERT availability.
- No significant correlation was found between SERT availability and memory function (r = 0.232, p = 0.581; r = 0.176, p = 0.677).
Conclusions:
- MDMA use acutely reduces SERT availability and impairs cognitive functions, particularly memory.
- SERT availability recovers with sustained abstinence, but memory function does not.
- SERT availability may not serve as a biomarker for MDMA-induced cognitive impairment or neurotoxicity.
More Related Videos
05:14Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
08:49Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
Related Concept Videos
Drugs Affecting Neurotransmitter Release or Uptake
Antidepressant Drugs: MAOIs and Other Agents
Drugs Affecting Neurotransmitter Synthesis
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Neurochemical Transmission: Sites of Drug Action